MAY 09, 2017 7:00 AM PDT

WEBINAR: Advanced assays for high-throughput assessment of ion channel inhibition and cardiac toxicity

Sponsored by: Molecular Devices
Speakers

Abstract

DATE: May 9th, 2017
TIME: 7:00AM PDT, 10:00AM ET, 2:00PM GMT

 

Early detection and elimination of new chemical entities with cardiac or hERG liability could substantially improve drug safety and minimize the cost of development. In this webinar, we will highlight different assays for validating ion channel inhibition using cell lines and cardiac toxicity using induced pluripotent stem cells (iPSCs).

High-throughput screening for in vitro potency evaluation of cardiac ion channel inhibitors on the FLIPR Tetra® System

Learning Objectives:

  • Optimize and validate a robust cell-based hERG fluorescence assay using the FLIPR® Potassium Assay Kit, a thallium-sensitive fluorescence dye to directly measure ion influx
  • Run inhibition assays with voltage-gated sodium channels (NaV1.5) and L-type voltage-gated calcium channels (CaV1.2) using FLIPR® Membrane Potential Dye and FLIPR® Calcium 6 Dye, respectively
  • Demonstrate high-throughput, early stage in vitro compound and potency assessment with comparable results from electrophysiological recording data

 

Multi-parameter in vitro assessment of compound effects on cardiomyocyte physiology using induced pluripotent stem cells

Learning Objectives:

  • Determine the effects of pharmacological compounds and other chemicals on the beating rate and profiles of cardiomyocytes using the FLIPR Tetra system and ImageXpress® Micro system. Assay data is characterized from 2D and 3D spheroid cardiomyocyte cultures. The assays employ calcium sensitive dyes to monitor changes in intracellular Ca2+ fluxes synchronous with cell beating which allows monitoring of beat rate, amplitude, and other parameters.
  • Identify methods for multiparametric analysis and ranking of compounds for potential cardiotoxic hazards. This methodology is well suited for testing environmental chemicals and early safety testing in drug development prior to clinical studies.

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
JUL 28, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUL 28, 2021 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 28, 2021 Time: 8:00am PDT Breast cancer is the most common form of cancer in women. It is estimated that 1 out of 8 women in the US will develop invasive breast cancer during her...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAY 09, 2017 7:00 AM PDT

WEBINAR: Advanced assays for high-throughput assessment of ion channel inhibition and cardiac toxicity

Sponsored by: Molecular Devices

Specialty

Molecular Biology

Cell Biology

Cancer Research

Biotechnology

Biochemistry

Clinical Diagnostics

Cell Culture

Laboratory Testing

Microbiology

Molecular Diagnostics

Biomarkers

Immunology

Cancer Therapeutics

Assay Development

Cancer Diagnostics

Geography

North America63%

Asia15%

Europe11%

Africa5%

South America4%

Registration Source

Website Visitors100%

Job Title

Student15%

Executive14%

Research Scientist12%

Facility/Department Manager11%

Scientist10%

Medical Laboratory Technician7%

Clinical Laboratory Scientist6%

Lab Management5%

Educator/Faculty5%

Post Doc4%

Medical Doctor/Specialist3%

Chemist2%

Consultant2%

Marketing/Sales2%

QC/QA1%

Pathologist1%

Toxicologist1%

Veterinarian1%

Organization

Academic Institution8%

Hospital6%

Clinical Laboratory5%

Biotech Company4%

Life Science Company4%

Research Institute4%

Pharmaceutical Company3%

Medical School2%

Consultant2%

Medical Center2%

Ambulatory Care1%

Industrial Company1%

Contract Research Organization (Cro)1%

Non-Profit Organization1%

Other4%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more